US2016287632A1PendingUtilityA1

Prevention of infarct expansion

Assignee: UNIV PENNSYLVANIAPriority: Sep 21, 2007Filed: Dec 8, 2015Published: Oct 6, 2016
Est. expirySep 21, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 9/10A61L 2400/06A61L 27/12A61L 27/54A61L 27/10A61L 2430/20A61K 33/42A61K 9/0019A61L 27/50A61K 9/14
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are methods and kits for safe and effective therapy that can be administered early after a heart attack in order to prevent progressive heart dilatation and resultant loss of function. The therapy includes the administration of particulate compositions to a region comprising an infarct or a portion thereof.

Claims

exact text as granted — not AI-modified
1 .- 16 . (canceled) 
     
     
         17 . A kit for use in the stabilization of cardiac infarct tissue comprising:
 a composition comprising a biologically compatible, acellular material comprising particles having characteristic dimensions of 25 μm to about 50 μm; and,   an injection tool capable of delivering said composition directly into a cardiac infarct itself, and optionally into a region of tissue containing the infarct, into tissue adjacent to or partially or completely surrounding the infarct, or both within a living patient.   
     
     
         18 . The kit according to  claim 17  wherein said material comprises microparticles of one or more forms of calcium phosphate. 
     
     
         19 . The kit according to  claim 17  wherein said composition comprises a suspension of said microparticles in an aqueous carrier. 
     
     
         20 . The kit according to  claim 17  wherein said injection tool comprises a catheter. 
     
     
         21 . The kit according to  claim 17  wherein said composition is provided in one or more premeasured aliquots. 
     
     
         22 .- 25 . (canceled)

Join the waitlist — get patent alerts

Track US2016287632A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.